Polycaprolactone scaffolds as a biomaterial for cementoblast delivery: An in vitro study

J Periodontal Res. 2022 Oct;57(5):1014-1023. doi: 10.1111/jre.13041. Epub 2022 Aug 5.

Abstract

Objective: To define the potential of polycaprolactone (PCL) scaffold for cementoblast delivery.

Background: Dental cementum is critical for tooth attachment and position, and its regenerative capabilities remain unpredictable.

Methods: PCL scaffolds were manufactured by the electrospinning technique at 10% and 20% (w/v) and seeded with cementoblasts (OCCM-30). Scaffolds were characterized for their morphology and biological performance by scanning electron microscopy (SEM), confocal and conventional histology, cytocompatibility (PrestoBlue assay), gene expression (type I collagen - Col1; bone sialoprotein - Bsp; runt-related transcription factor 2 - Runx-2; alkaline phosphatase - Alpl; osteopontin - Opn; osteocalcin - Ocn, osterix - Osx), and the potential to induce extracellular matrix deposition and mineralization in vitro.

Results: Overall, data analysis showed that PCL scaffolds allowed cell adhesion and proliferation, modulated the expression of key markers of cementoblasts, and led to enhanced extracellular matrix deposition and calcium deposition as compared to the control group.

Conclusion: Altogether, our findings allow concluding that PCL scaffolds are a viable tool to culture OCCM-30 cells, leading to an increased potential to promote mineralization in vitro. Further studies should be designed in order to define the clinical relevance of cementoblast-loaded PCL scaffolds to promote new cementum formation.

Keywords: cementoblast; polycaprolactone; regeneration; scaffolds.

MeSH terms

  • Biocompatible Materials*
  • Cell Differentiation
  • Dental Cementum*
  • Integrin-Binding Sialoprotein / metabolism
  • Polyesters
  • Tissue Scaffolds

Substances

  • Biocompatible Materials
  • Integrin-Binding Sialoprotein
  • Polyesters
  • polycaprolactone